EFNB2 and pancreatic ductal adenocarcinoma: EFNB2 acts as a oncogene in pancreatic ductal adenocarcinoma (PDAC) and is markedly upregulated in PDAC and correlated to clinical stage and Ki67 expression levels in PDAC [36, 37].